The non-dilutive money that is not on Grants.gov
Disease foundations run venture-philanthropy arms, states pay you on top of a federal award, and none of it is indexed in one place. This is the money with the least competition.
Federal databases are the obvious place to look, which is exactly why they are the most competitive. The harder-to-find money is not smaller. It is just scattered across hundreds of individual websites with no shared index.
Three categories are worth knowing.
Disease foundations with venture-philanthropy arms
Large patient foundations do not only fund academic labs. Several run company-facing programmes that write translational cheques, structured with milestones rather than as academic grants, and some run investment arms alongside the philanthropy.
The most famous example is the Cystic Fibrosis Foundation's role in funding therapeutic development, but the model is now common across rare disease, oncology, neurology, and metabolic conditions.
Why they are attractive: they are indication-specific, so a company working squarely in their disease is competing against a small, self-selected field rather than everyone.
State programmes, especially SBIR match
This is the one founders are most surprised by. A number of states pay companies on top of a federal SBIR or STTR award, sometimes substantially, simply for being located there. If you have already won a federal Phase I, some of that money is sitting unclaimed.
Others run their own translational funding for companies that have not raised federal money yet, and a few states operate life-science-specific agencies with loans and early commercialisation grants.
The catch is real but simple: residency requirements are usually hard. You either qualify or you do not, which at least makes the decision fast.
Institutes that give services instead of cash
Some federal programmes provide in-kind development support — medicinal chemistry, toxicology, manufacturing, assay development — rather than a cheque. For a small team, access to that infrastructure can be worth more than the equivalent cash, because you could not buy it efficiently at your scale anyway.
Why nobody has a list
Because there is no feed. Foundations publish on their own sites in their own formats and change programmes without notice. States publish through economic development agencies that do not think of themselves as science funders. Nothing aggregates it, and a chat session cannot enumerate it reliably because it is not in one place to enumerate.
We maintain a curated directory of these funders, matched to your disease area and your state, with every link checked before it ships. We deliberately do not restate their deadlines or award sizes — those change, and a stale deadline is worse than no deadline — so each entry points at the funder's own page.
It is in the product under Beyond Grants.gov.
Stop finding out too late.
SixthGrant reads every federal solicitation daily, checks each one against your company, and tells you what changed.
See what it costs →